263 related articles for article (PubMed ID: 12461411)
1. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA
AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands.
Ghezzi S; Menzo S; Brambilla A; Bordignon PP; Lorini AL; Clementi M; Poli G; Vicenzi E
Virology; 2001 Feb; 280(2):253-61. PubMed ID: 11162839
[TBL] [Abstract][Full Text] [Related]
3. HIV co-receptors as targets for antiviral therapy.
Schols D
Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists.
Princen K; Hatse S; Vermeire K; De Clercq E; Schols D
Retrovirology; 2004 Mar; 1():2. PubMed ID: 15169555
[TBL] [Abstract][Full Text] [Related]
7. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA.
Anderson J; Banerjea A; Planelles V; Akkina R
AIDS Res Hum Retroviruses; 2003 Aug; 19(8):699-706. PubMed ID: 13678472
[TBL] [Abstract][Full Text] [Related]
8. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
9. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
Anderson J; Banerjea A; Akkina R
Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
[TBL] [Abstract][Full Text] [Related]
10. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
11. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
De Clercq E; Schols D
Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
[TBL] [Abstract][Full Text] [Related]
13. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
[TBL] [Abstract][Full Text] [Related]
15. CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
Moonis M; Lee B; Bailer RT; Luo Q; Montaner LJ
AIDS; 2001 Oct; 15(15):1941-9. PubMed ID: 11600821
[TBL] [Abstract][Full Text] [Related]
16. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages.
Song E; Lee SK; Dykxhoorn DM; Novina C; Zhang D; Crawford K; Cerny J; Sharp PA; Lieberman J; Manjunath N; Shankar P
J Virol; 2003 Jul; 77(13):7174-81. PubMed ID: 12805416
[TBL] [Abstract][Full Text] [Related]
17. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.
Schmitt N; Chêne L; Boutolleau D; Nugeyre MT; Guillemard E; Versmisse P; Jacquemot C; Barré-Sinoussi F; Israël N
J Virol; 2003 May; 77(10):5784-93. PubMed ID: 12719571
[TBL] [Abstract][Full Text] [Related]
18. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG
J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247
[TBL] [Abstract][Full Text] [Related]
19. Induction of interleukins IL-6 and IL-8 by siRNA.
Pauls E; Senserrich J; Bofill M; Clotet B; Esté JA
Clin Exp Immunol; 2007 Jan; 147(1):189-96. PubMed ID: 17177979
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
